Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Ciprofloxacin in Plasmid-Mediated AMR Research
2026-09-28
Ciprofloxacin can do more than benchmark antibacterial activity: it can help researchers separate resistance phenotype, gene carriage, plasmid transfer, and clonal spread. This article translates recent carbapenem-resistant Enterobacter cloacae findings into a practical assay-design framework.
-
Vincristine Sulfate: Practical Cancer Assay Guide
2026-09-28
Use Vincristine sulfate to probe microtubule disruption and antiproliferative responses across cancer models, with a workflow that separates drug handling, dose selection, and orthogonal readouts. The guide turns reported potency into a practical starting point while emphasizing vehicle controls, model-specific optimization, and limits on cross-domain interpretation.
-
Mitochondrial Calcium Signaling Represses Ferroptosis
2026-09-27
The study links mitochondrial calcium uptake through MCU to acetyl-CoA-dependent GPX4 acetylation, identifying a metabolic route that sustains resistance to ferroptotic cell death. Its mouse, mechanistic, and tumor-model findings suggest testable connections between mitochondrial metabolism and ferroptosis, while leaving the clinical and compound-specific implications open.
-
Vincristine sulfate: Reliable Assay Design
2026-09-26
A scenario-driven guide to using Vincristine sulfate (SKU A1765) in cell viability, proliferation, and cytotoxicity workflows. It explains how to design cell-specific dose responses, prepare stocks, interpret assay endpoints, and assess product options without treating a single benchmark as universal.
-
Ethacridine Lactate Monohydrate in Assay Design
2026-09-25
Ethacridine lactate monohydrate can support research workflows that require antiseptic activity, but its role must be separated from the biology being measured. This article connects practical reagent controls with YAP–TEAD super-enhancer research to help researchers protect causal interpretation in cell-differentiation assays.
-
Deep Learning Screens iPSC Cardiomyocytes for Cardiotoxicity
2026-09-25
Grafton and colleagues combined induced pluripotent stem cell-derived cardiomyocytes with deep-learning analysis of high-content images to identify compounds associated with cardiotoxic phenotypes. Screening a bioactive library and a separate set of molecules with unknown targets showed how a compact image-based score can support early toxicity triage, while leaving clinical risk prediction and mechanism-specific follow-up to further testing.
-
Sumatriptan’s Anti-Inflammatory Evidence: A Review
2026-09-24
Ala and colleagues systematically reviewed evidence that sumatriptan may influence inflammatory signaling beyond its established use in migraine, including effects on cytokines, nitric oxide pathways, and CGRP release. Their synthesis highlights promising protection across experimental injury models, while the mainly preclinical evidence and variation among studies mean that these findings do not establish new clinical indications.
-
T0070907 for Testing PPARγ in Vascular SASP
2026-09-24
T0070907 is a potent PPARγ antagonist that can help researchers test whether PPARγ activity contributes to anti-inflammatory signaling in foam cells. This article translates recent RXRα/PPARγ/NEDD4 findings into a careful assay strategy, emphasizing causal interpretation, species limits, and orthogonal validation.
-
3-Hydroxybutyrate (BHBA) for Stroke Assays
2026-09-23
Use 3-hydroxybutyrate (BHBA) to test whether a defined ketone-body signal can support neuronal resilience during ischemia-like stress. This practical guide separates BHBA-specific effects from mixed-ketone findings and pairs dose selection with ferroptosis-focused readouts and troubleshooting.
-
Vitamin C: Redox Logic for Senescence Assays
2026-09-23
Vitamin C is a context-dependent redox regulator with distinct effects in tumor and cochlear cell models. This article translates ROS/NF-κB evidence into practical assay decisions, dose interpretation, and translational limits.
-
Fiber Density Reconstructs Annulus Fibrosus Collagen
2026-09-22
The reference study shows that fiber density in otherwise composition-matched electrospun scaffolds can direct annulus fibrosus cell phenotypes toward collagen type I- or collagen type II-rich matrix programs. Its mechanistic findings connect scaffold microarchitecture with RhoA–ROCK, ERK/AKT, and Piezo1-associated signaling, offering a design principle for rebuilding the native collagen heterogeneity of the annulus fibrosus.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-22
Grafton et al. developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify potential drug-induced cardiotoxicity. The approach produced a single-parameter toxicity score across bioactive and chemically diverse libraries, offering an early-stage strategy for prioritizing compounds that require mechanistic and safety follow-up.
-
Bafilomycin C1 in High-Content Cell Assays
2026-09-21
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal pH control with rigorous high-content assay design. This guide translates deep-learning phenotyping in iPSC-derived cardiomyocytes into practical decisions for autophagy, toxicity, and mechanistic cell biology workflows.
-
Butyrate, Lysosomal Fe2+, and Lung Cancer Stemness
2026-09-21
The Heliyon study shows that butyrate attenuates lung cancer stemness through a ferroptosis mechanism involving lysosomal Fe2+ recruitment and reduced SLC7A11 protein stability. Its combined functional, molecular, and in vivo design connects subcellular iron handling with cancer stem cell behavior and chemotherapy sensitivity.
-
Diphenyleneiodonium Chloride in Redox Assays
2026-09-20
Diphenyleneiodonium chloride enables controlled interrogation of oxidant-generating enzymes while also revealing GPR3-linked cAMP responses. This workflow pairs DPI pharmacology with time-resolved Nrf2 measurements to separate early oxidative signaling from later proteasome-associated pathway loss.